Results 91 to 100 of about 26,355 (200)

Gene therapy of hypoparathyroidism with TheraCyte-encapsulated stem cells [PDF]

open access: yes, 2010
The parathyroid hormone (PTH) (1-34) gene was inserted into a pcDNA3 promoter and E. coli competent cells were used to amplify the cDNA. C3H/10T1/2 stem cells were transfected with PTH (1-34) cDNA using Lipofectamine reagents.
Shun-Chen Huang   +5 more
core   +1 more source

Collision tumor: a parathyroid adenoma unveiling subclinical widespread breast carcinoma: a case report

open access: yesJournal of Medical Case Reports
Background Collision tumors are rare but well-documented phenomena, where two distinct tumors of different origins are found together. We present a unique case of a parathyroid adenoma revealing a subclinical widespread breast carcinoma.
Sarra Yacoub   +5 more
doaj   +1 more source

Diagnosis and treatment challenges of parathyroid carcinoma in a 27-year-old woman with multiple lung metastases

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2017
Parathyroid carcinoma is an extremely rare disorder with little treatment options. It could be misdiagnosed in medical centers with little experience in management of such cases.
Liudmila Rozhinskaya   +12 more
doaj   +1 more source

Focus on parathyroid carcinoma

open access: yesInternational Journal of Surgery, 2011
Parathyroid carcinoma is a malignant neoplasm affecting 05-2 per cent of all patients with primary hyperparathyroidism that was first described by de Quevain in 1904. To day it continues to defy diagnosis and treatment. It is difficult to diagnose in part because of its rarity, lack of definitive diagnostic markers and overlapping clinical features of ...
Kassahun, Woubet T., Jonas, Sven
openaire   +2 more sources

Brain metastases of parathyroid carcinoma: Review of the literature and a case report

open access: yesBiomedical Papers, 2015
Background: Parathyroid carcinoma is a rare tumor typically presenting with marked elevations of serum calcium concentrations and associated renal and skeletal symptoms.
Hana Studentova   +6 more
doaj   +1 more source

Parafibromin as a Diagnostic Instrument for Parathyroid Carcinoma-Lone Ranger or Part of the Posse?

open access: yesInternational Journal of Endocrinology, 2010
The diagnosis of parathyroid carcinoma requires an invasive growth pattern or metastases detected at histopathological examination; unfortunately, not all carcinomas exhibit visible malignant properties at the initial assessment.
C. Christofer Juhlin, Anders Höög
doaj   +1 more source

Intrathyroidal parathyroid carcinoma: a case report with clinical and histological findings

open access: yesDiagnostic Pathology, 2008
The chance of an intrathyroidal occurrence of a parathyroid gland is about 1–3%. Among the causes of hyperparathyroidism, parathyroid cases occur in less than 1% of patients.
Al-Sanea Osama   +4 more
doaj   +1 more source

Parathyroid carcinoma: a 16-year experience in a single institution [PDF]

open access: yes, 2010
INTRODUCTION: This study aims to describe our experiences of parathyroid carcinoma. MATERIALS AND METHODS: The data of clinicopathological features, surgical treatment and outcomes of seven cases of parathyroid carcinoma among 171 patients who underwent
정웅윤   +5 more
core   +1 more source

Multimodality imaging in parathyroid carcinoma: A tale of two nodules

open access: yesRadiology Case Reports, 2015
Parathyroid carcinoma is a rare cause of primary hyperparathyroidism. Clinical indicators of carcinoma include the severity of hyperparathyroidism and presence of a palpable neck mass.
AR Walton, MBBS, FRANZCR   +2 more
doaj   +1 more source

Somatostatin receptor expression in parathyroid neoplasms

open access: yesEndocrine Connections, 2019
Introduction: Parathyroid carcinoma represents a rare cause of primary hyperparathyroidism. Distinguishing carcinoma from the benign tumors underlying primary hyperparathyroidism remains challenging.
Sara Storvall   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy